Company data
Neurogene Inc. employees and revenue per employee
NGNE · Biotechnology · $417M market cap
Neurogene Inc. had 107 employees at the end of fiscal Dec 2024. Revenue for the year was $925,000, or $9K per employee.
Employees
107
Revenue
$925,000
Revenue / employee
$9K
Peer median $459K
Rank in industry
104 of 108
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Only one fiscal year on file so far, so there is no trend to draw yet.
Neurogene Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| CGON CG Oncology Inc. | 142 | $4.0M | $28K | Efficient growth |
| STTK Shattuck Labs, Inc. | 40 | $1.0M | $25K | Contracting |
| DNTH Dianthus Therapeutics, Inc. | 92 | $2.0M | $22K | Hiring into decline |
| ABSI Absci Corporation | 140 | $2.8M | $20K | Contracting |
| INBX Inhibrx Biosciences Inc. | 109 | $1.3M | $12K | Leaner |
| NGNE Neurogene Inc. | 107 | $925,000 | $9K | — |
| CLDX Celldex Therapeutics, Inc. | 198 | $1.5M | $8K | Hiring into decline |
| ARTV Artiva Biotherapeutics, Inc. | 89 | $251,000 | $3K | — |
| AKTS Aktis Oncology, Inc. | 200,000 | $6.5M | $32 | — |
Questions about Neurogene Inc.
- How many employees does Neurogene Inc. have?
- Neurogene Inc. reported 107 employees for the fiscal year ending Dec 2024, in the annual report it filed on March 24, 2025.
- What is Neurogene Inc.'s revenue per employee?
- Neurogene Inc. brought in $925,000 of revenue in fiscal Dec 2024, which is $9K per employee. That ranks 104 of 108 companies we track in Biotechnology, where the median is $459K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare NGNE with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Neurogene Inc.'s annual reports (Form 10-K), latest filed March 24, 2025. This is data, not a recommendation to buy or sell NGNE.